Patients gastroenteropancreatic and thoracic (carcinoid) neuroendocrine neoplasms in the COVID-19 era

By Neuroendocrine Cancer UK

Posted 6 years ago

20/01/2021 1pm

Practical recommendations for the management of patients with gastroenteropancreatic and thoracic (carcinoid) neuroendocrine neoplasms in the COVID-19 era.

Read full journal here

Catch up on the latest news, stories and updates

Ongoing variability in the supply of pancreatic enzyme replacement therapy (PERT) — particularly Creon® 25,000iu capsules — has left some people struggling to obtain their prescription. ...